CD38 and neoplasm: While CD38 expressed on tumour cells can mediate immune resistance by providing precursors for adenosine generation via the non-canonical pathway mediated by ENPP1 (CD203a) and CD73 (67, 68), its NADase function in immune cells is important for protection against ART-mediated NICD under NAD-rich conditions (Figure 1).